Transient ectopic expression as a method to detect genes conferring drug resistance
James Witham1, Susanne Vidot, Roshan Agarwal
1Section of Medicine, The Institute of Cancer Research, Sutton, United Kingdom.
Transient gene expression can identify drug resistance genes. This method, using a novel vector, detected sensitivity changes in Sk-Ov-3 cells to carboplatin and paclitaxel, offering a new screening approach.
Area of Science:
- Genomics
- Molecular Biology
- Drug Discovery
Background:
- Functional genomic screens are crucial for identifying genes involved in cellular processes.
- RNA interference (RNAi) is a common method for gene silencing in screens.
- Ectopic gene expression offers an alternative approach for functional genomic studies.
Purpose of the Study:
- To evaluate the utility of transient gene expression for identifying genes that confer drug resistance.
- To develop and optimize a high-throughput screening method using ectopic expression.
Main Methods:
- Construction of a bigenic vector for high-throughput cloning and transfection monitoring via red fluorescent protein.
- Optimization of assay conditions to detect changes in drug sensitivity.
- Transient expression of specific genes (MDR-1, MCJ, Src, Bcl-2, Bcl-X(L)) in Sk-Ov-3 cells.
Main Results:
- Transient expression of MDR-1 and MCJ altered Sk-Ov-3 cell sensitivity to paclitaxel.
- Expression of Src, Bcl-2, and Bcl-X(L) decreased Sk-Ov-3 cell sensitivity to carboplatin.
- The method successfully detected changes in drug sensitivity based on gene expression.
Conclusions:
- Transient gene expression is a viable method for identifying drug resistance genes.
- This approach can serve as an independent screening tool or complement existing methods like RNAi.
- The developed vector and optimized assays facilitate high-throughput functional genomic screening for drug resistance.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenomics: Identification of New Drug Targets
Reporter Genes
Commonly used reporter...
